IBDEI2FY ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,38994,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,38994,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,38995,0)
 ;;=L30.0^^152^1990^270
 ;;^UTILITY(U,$J,358.3,38995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38995,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,38995,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,38995,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,38996,0)
 ;;=L30.1^^152^1990^143
 ;;^UTILITY(U,$J,358.3,38996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38996,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,38996,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,38996,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,38997,0)
 ;;=L30.2^^152^1990^135
 ;;^UTILITY(U,$J,358.3,38997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38997,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,38997,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,38997,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,38998,0)
 ;;=L30.4^^152^1990^147
 ;;^UTILITY(U,$J,358.3,38998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38998,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,38998,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,38998,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,38999,0)
 ;;=L30.8^^152^1990^138
 ;;^UTILITY(U,$J,358.3,38999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38999,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,38999,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,38999,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,39000,0)
 ;;=L30.9^^152^1990^139
 ;;^UTILITY(U,$J,358.3,39000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39000,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,39000,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,39000,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,39001,0)
 ;;=L40.0^^152^1990^293
 ;;^UTILITY(U,$J,358.3,39001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39001,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,39001,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,39001,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,39002,0)
 ;;=L40.1^^152^1990^296
 ;;^UTILITY(U,$J,358.3,39002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39002,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,39002,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,39002,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,39003,0)
 ;;=L40.2^^152^1990^12
 ;;^UTILITY(U,$J,358.3,39003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39003,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,39003,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,39003,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,39004,0)
 ;;=L40.3^^152^1990^295
 ;;^UTILITY(U,$J,358.3,39004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39004,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,39004,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,39004,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,39005,0)
 ;;=L40.4^^152^1990^160
 ;;^UTILITY(U,$J,358.3,39005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39005,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,39005,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,39005,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,39006,0)
 ;;=L40.8^^152^1990^292
 ;;^UTILITY(U,$J,358.3,39006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39006,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,39006,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,39006,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,39007,0)
 ;;=L40.9^^152^1990^294
 ;;^UTILITY(U,$J,358.3,39007,1,0)
 ;;=^358.31IA^4^2
